Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page
- Check7 days agoChange DetectedRecord history shows the addition of Revision v3.5.2 and removal of Revision v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new site revision entry (Revision: v3.5.0) was added and the previous entry (Revision: v3.4.3) was removed from the record history.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision v3.4.3 is added and revision v3.4.2 is removed from the history.SummaryDifference0.1%

- Check71 days agoChange DetectedVersion 6 adds core study record sections—Study Design, Study Description, Sponsor/Collaborators, Study Status, and Study Identification (revision: v3.4.2). It also removes the previous government funding notice and the AnHeart Therapeutics reference.SummaryDifference3%

- Check78 days agoChange DetectedA site-wide notice about government funding was added and the site version updated from v3.4.0 to v3.4.1; the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check85 days agoChange DetectedThe history page now shows a 'Show glossary' option and legends for green additions and red deletions, and the revision version was updated to v3.4.0 with a No FEAR Act Data entry.SummaryDifference1%

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.